Advertisement
YOU ARE HERE: LAT HomeCollections

Business Briefing / Pharmaceuticals

Raptiva may have link to infection

February 20, 2009|Times Wire Reports

Three patients taking the Genentech Inc. drug Raptiva are believed to have died of a rare brain infection, a known risk with the skin-clearing treatment, according to federal health officials.

The Food and Drug Administration confirmed three cases and a possible fourth of progressive multifocal leukoencephalopathy, or PML, which causes swelling of the brain and is usually fatal. All the cases were reported in the last six months.

Advertisement
Los Angeles Times Articles
|
|
|